243 related articles for article (PubMed ID: 18191875)
21. Concentration of calcium and magnesium and trace elements (zinc, copper, iron and manganese) in cerebrospinal fluid: a try of a pathophysiological classification.
Romarís EM; Cervantes II; López JM; Marcén JF
J Trace Elem Med Biol; 2011 Jan; 25 Suppl 1():S45-9. PubMed ID: 21146970
[TBL] [Abstract][Full Text] [Related]
22. Electroencephalogram variability in dementia with lewy bodies, Alzheimer's disease and controls.
Andersson M; Hansson O; Minthon L; Rosén I; Londos E
Dement Geriatr Cogn Disord; 2008; 26(3):284-90. PubMed ID: 18841014
[TBL] [Abstract][Full Text] [Related]
23. EEG comparisons in early Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease with dementia patients with a 2-year follow-up.
Bonanni L; Thomas A; Tiraboschi P; Perfetti B; Varanese S; Onofrj M
Brain; 2008 Mar; 131(Pt 3):690-705. PubMed ID: 18202105
[TBL] [Abstract][Full Text] [Related]
24. Serum sialic acid levels and selected mineral status in patients with type 2 diabetes mellitus.
Ekin S; Mert N; Gunduz H; Meral I
Biol Trace Elem Res; 2003 Sep; 94(3):193-201. PubMed ID: 12972687
[TBL] [Abstract][Full Text] [Related]
25. Cerebrospinal fluid neuron-specific enolase: a further marker of Alzheimer's disease?
Palumbo B; Siepi D; Sabalich I; Tranfaglia C; Parnetti L
Funct Neurol; 2008; 23(2):93-6. PubMed ID: 18671910
[TBL] [Abstract][Full Text] [Related]
26. Patterns of levels of biological metals in CSF differ among neurodegenerative diseases.
Hozumi I; Hasegawa T; Honda A; Ozawa K; Hayashi Y; Hashimoto K; Yamada M; Koumura A; Sakurai T; Kimura A; Tanaka Y; Satoh M; Inuzuka T
J Neurol Sci; 2011 Apr; 303(1-2):95-9. PubMed ID: 21292280
[TBL] [Abstract][Full Text] [Related]
27. Follow-up investigations in cerebrospinal fluid of patients with dementia with Lewy bodies and Alzheimer's disease.
Mollenhauer B; Bibl M; Trenkwalder C; Stiens G; Cepek L; Steinacker P; Ciesielczyk B; Neubert K; Wiltfang J; Kretzschmar HA; Poser S; Otto M
J Neural Transm (Vienna); 2005 Jul; 112(7):933-48. PubMed ID: 15937638
[TBL] [Abstract][Full Text] [Related]
28. CSF orexin levels of Parkinson's disease, dementia with Lewy bodies, progressive supranuclear palsy and corticobasal degeneration.
Yasui K; Inoue Y; Kanbayashi T; Nomura T; Kusumi M; Nakashima K
J Neurol Sci; 2006 Dec; 250(1-2):120-3. PubMed ID: 17005202
[TBL] [Abstract][Full Text] [Related]
29. Dementia severity and Lewy bodies affect circadian rhythms in Alzheimer disease.
Harper DG; Stopa EG; McKee AC; Satlin A; Fish D; Volicer L
Neurobiol Aging; 2004 Jul; 25(6):771-81. PubMed ID: 15165702
[TBL] [Abstract][Full Text] [Related]
30. Neprilysin activity in cerebrospinal fluid is associated with dementia and amyloid-β42 levels in Lewy body disease.
Maetzler W; Stoycheva V; Schmid B; Schulte C; Hauser AK; Brockmann K; Melms A; Gasser T; Berg D
J Alzheimers Dis; 2010; 22(3):933-8. PubMed ID: 20858953
[TBL] [Abstract][Full Text] [Related]
31. The cognitive profile and CSF biomarkers in dementia with Lewy bodies and Parkinson's disease dementia.
Andersson M; Zetterberg H; Minthon L; Blennow K; Londos E
Int J Geriatr Psychiatry; 2011 Jan; 26(1):100-5. PubMed ID: 21157855
[TBL] [Abstract][Full Text] [Related]
32. Utility of the Bender Gestalt Test for differentiation of dementia with Lewy bodies from Alzheimer's disease in patients showing mild to moderate dementia.
Murayama N; Iseki E; Yamamoto R; Kimura M; Eto K; Arai H
Dement Geriatr Cogn Disord; 2007; 23(4):258-63. PubMed ID: 17351317
[TBL] [Abstract][Full Text] [Related]
33. Soluble adhesion molecules and angiotensin-converting enzyme in dementia.
Nielsen HM; Londos E; Minthon L; Janciauskiene SM
Neurobiol Dis; 2007 Apr; 26(1):27-35. PubMed ID: 17270454
[TBL] [Abstract][Full Text] [Related]
34. A failure of 'pop-out' in visual search tasks in dementia with Lewy Bodies as compared to Alzheimer's and Parkinson's disease.
Cormack F; Gray A; Ballard C; Tovée MJ
Int J Geriatr Psychiatry; 2004 Aug; 19(8):763-72. PubMed ID: 15290700
[TBL] [Abstract][Full Text] [Related]
35. Alpha-synuclein in the cerebrospinal fluid differentiates synucleinopathies (Parkinson Disease, dementia with Lewy bodies, multiple system atrophy) from Alzheimer disease.
Tateno F; Sakakibara R; Kawai T; Kishi M; Murano T
Alzheimer Dis Assoc Disord; 2012; 26(3):213-6. PubMed ID: 22037599
[TBL] [Abstract][Full Text] [Related]
36. Transthyretin as a potential CSF biomarker for Alzheimer's disease and dementia with Lewy bodies: effects of treatment with cholinesterase inhibitors.
Schultz K; Nilsson K; Nielsen JE; Lindquist SG; Hjermind LE; Andersen BB; Wallin A; Nilsson C; Petersén A
Eur J Neurol; 2010 Mar; 17(3):456-60. PubMed ID: 19922456
[TBL] [Abstract][Full Text] [Related]
37. Survival and mortality differences between dementia with Lewy bodies vs Alzheimer disease.
Williams MM; Xiong C; Morris JC; Galvin JE
Neurology; 2006 Dec; 67(11):1935-41. PubMed ID: 17159097
[TBL] [Abstract][Full Text] [Related]
38. Biological markers in cerebrospinal fluid (CSF) and evaluation of in vitro effect of CSF on PC12 cell line viability in Alzheimer's disease.
Yaka E; Egrilmez MY; Keskinoglu P; Cavdar Z; Genc S; Genc K; Iyilikci L; Yener GG
Cell Biochem Funct; 2009 Aug; 27(6):395-401. PubMed ID: 19639578
[TBL] [Abstract][Full Text] [Related]
39. Circadian characteristics of serum calcium, magnesium and eight trace elements and of their metallo-moieties in urine of healthy middle-aged men.
Kanabrocki EL; Sothern RB; Ryan MD; Kahn S; Augustine G; Johnson C; Foley S; Gathing A; Eastman G; Friedman N; Nemchausky BA; Kaplan E
Clin Ter; 2008; 159(5):329-46. PubMed ID: 18998036
[TBL] [Abstract][Full Text] [Related]
40. Heart fatty acid binding protein as a potential diagnostic marker for neurodegenerative diseases.
Steinacker P; Mollenhauer B; Bibl M; Cepek L; Esselmann H; Brechlin P; Lewczuk P; Poser S; Kretzschmar HA; Wiltfang J; Trenkwalder C; Otto M
Neurosci Lett; 2004 Nov; 370(1):36-9. PubMed ID: 15489013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
